Rebecca E Chandler (Rebecca Chandler)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Clinical Decision Support

Infectious Diseases

Idiopathic Pulmonary Fibrosis

Top Venues

BMJ global health

Pharmacoepidemiology and drug safety

Pharmaceutical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Emmanuelle Espie, Katharina Hartmann, Corinne Jouquelet-Royer, James Milligan, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen, null null
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. BMJ global health 9 (3) (2024)
Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Emmanuelle Espie, Katharina Hartmann, Corinne Jouquelet-Royer, James Milligan, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen, null null
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. BMJ global health 9 (3) (2024)
Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Emmanuelle Espie, Katharina Hartmann, Corinne Jouquelet-Royer, James Milligan, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen, null null
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. BMJ global health 9 (3) (2024)
Suneth Buddhika Agampodi, Ondari D Mogeni, Rebecca E Chandler, Megha Pansuriya, Jerome H Kim, Jean-Louis Excler
Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution. Expert review of vaccines 23 (1) (2024)
Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Emmanuelle Espie, Katharina Hartmann, Corinne Jouquelet-Royer, James Milligan, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen, null null
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. BMJ global health 9 (3) (2024)
Rebecca E Chandler, Madhava Ram Balakrishnan, Daniel Brasseur, Philip Bryan, Emmanuelle Espie, Katharina Hartmann, Corinne Jouquelet-Royer, James Milligan, Linda Nesbitt, Shanthi Pal, Alexander Precioso, Paulo Takey, Robert T Chen, null null
Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX Vaccine Safety Working Group. BMJ global health 9 (3) (2024)
Rani Lill Anjum, Rebecca E Chandler, Elena Rocca
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets. Pharmaceutical medicine 36 (3) (2022)
Rebecca E Chandler
The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities. Drug safety 45 (6) (2022)
Corine Ekhart, Florence P A M van Hunsel, Eugene P van Puijenbroek, Rebecca E Chandler, Eva-Lisa Meldau, Henric Taavola, G Niklas Norén
Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports. Drug safety 45 (2) (2022)
Lovisa Sandberg, Henric Taavola, Yasunori Aoki, Rebecca E Chandler, G Niklas Norén
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase. Drug safety 43 (10) (2021)
Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki, Rebecca E Chandler
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan. Drug safety 44 (6) (2021)
Karsten Juhl Jørgensen, Margrete Auken, Louise Brinth, Rebecca E Chandler, Peter C Gøtzsche, Tom Jefferson
Suspicions of possible vaccine harms must be scrutinised openly and independently to ensure confidence. NPJ vaccines 5 (1) (2020)
Rebecca E Chandler
Optimizing safety surveillance for COVID-19 vaccines. Nature reviews. Immunology 20 (8) (2020)
Rebecca E Chandler, Deirdre McCarthy, Jean-Christophe Delumeau, Mira Harrison-Woolrych
The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic. Drug safety 43 (6) (2020)
Rebecca E Chandler
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases. Pharmacoepidemiology and drug safety 29 (8) (2020)
Rebecca E Chandler
Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: A signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions. Pharmacoepidemiology and drug safety 28 (3) (2018)